Concepedia

Yumi Ohtani

YO

4

Publications

63

Citations

4

H-Index

2017

Active since

Affiliations

Carisma Therapeutics (United States)(Current)

University of Pennsylvania

Yumi Ohtani is an author at Carisma Therapeutics (United States) specializing in immunology, tumor immunity, and t cell immunity.

ORCID

Top concepts

Publications per year

2017–2021

4

Publications

4

Abstract 63: Chimeric antigen receptor macrophages (CAR-M) induce anti-tumor immunity and synergize with T cell checkpoint inhibitors in pre-clinical solid tumor models

Stefano Pierini, Rashid Gabbasov, Linara Gabitova et al. · Cancer Research · 2021 · 23 citations

, , +20

MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia

Kostandin V. Pajcini, Lanwei Xu, Lijian Shao et al. · Science Signaling · 2017 · 19 citations · Full text

Abstract 1530: Anti-HER2 CAR monocytes demonstrate targeted anti-tumor activity and enable a single day cell manufacturing process

Linara Gabitova, Brett Menchel, Rashid Gabbasov et al. · Cancer Research · 2021 · 11 citations

128 Development of an M1-polarized, non-viral chimeric antigen receptor macrophage (CAR-M) platform for cancer immunotherapy

Yumi Ohtani, Kayleigh C. Ross, Aditya Dandekar et al. · Regular and Young Investigator Award Abstracts · 2020 · 10 citations · Full text

Rows per page

1–4 of 4